Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment. [electronic resource]
Producer: 20150120Description: e31-3 p. digitalISSN:- 1556-1380
- Adenocarcinoma -- drug therapy
- Amino Acid Sequence
- Base Sequence
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Exons -- genetics
- Female
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Middle Aged
- Molecular Sequence Data
- Mutagenesis, Insertional -- genetics
- Neoplasm Staging
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.